| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 15.744 | 409.881 | 457.138 | 499.274 |
| Total Income - EUR | - | - | - | - | - | - | 15.745 | 409.881 | 457.440 | 499.372 |
| Total Expenses - EUR | - | - | - | - | - | - | 15.281 | 320.476 | 391.585 | 441.917 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 463 | 89.405 | 65.855 | 57.454 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1 | 85.307 | 61.281 | 42.473 |
| Employees | - | - | - | - | - | - | 0 | 2 | 2 | 2 |
Check the financial reports for the company - Akeso Medical Innovations S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 815 | 2.394 | 38.739 | 68.113 |
| Current Assets | - | - | - | - | - | - | 11.504 | 123.764 | 178.915 | 69.831 |
| Inventories | - | - | - | - | - | - | 1.854 | 6.269 | 15.329 | 28.605 |
| Receivables | - | - | - | - | - | - | 1.163 | 14.061 | 76.113 | 31.190 |
| Cash | - | - | - | - | - | - | 8.487 | 103.434 | 87.472 | 10.036 |
| Shareholders Funds | - | - | - | - | - | - | 41 | 85.348 | 133.148 | 70.691 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 12.279 | 40.810 | 97.548 | 67.252 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 24.214 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Akeso Medical Innovations S.r.l.